Fish oil has been sold as a fix for almost everything, and now it is being pitched as a defense against the muscle loss that comes with age. A new umbrella review pulled together the best available evidence on omega-3s and aging muscle. The answer is more interesting, and more modest, than the supplement-aisle hype.
The Study at a Glance
The paper, by Shao and colleagues, appeared in the International Journal for Vitamin and Nutrition Research (2026;96(5)). It is an umbrella review, meaning a review of existing evidence rather than a new trial. The team searched PubMed, Web of Science, EBSCO, and ScienceDirect for randomized controlled trials (RCTs) and meta-analyses of RCTs. All of them tested n-3 polyunsaturated fatty acid (n-3 PUFA) supplementation on muscle outcomes in adults aged 55 and older.
Seven RCTs and seven meta-analyses made the cut, which is where the "14 studies" figure comes from. The review was registered in PROSPERO (CRD420251165901). It rated the meta-analyses with AMSTAR 2 and the certainty of the evidence with GRADE. It also measured how much the included studies overlapped, using the corrected covered area (CCA).
What Was Actually Tested
Most of the interventions used mixtures rich in EPA and DHA, the marine omega-3s found in fish oil. A few used flaxseed oil, which is rich in plant-based ALA. Doses varied enormously, from 1.3 g/day to 14 g/day, and interventions ran from 6 weeks to 6 months. The primary outcomes were skeletal muscle mass, muscle strength, and physical function.
That range matters. The review did not identify one proven dose, so anyone claiming the "optimal" milligram amount for muscle is going beyond this evidence.
The Headline Finding: Modest, But Measurable
Overall, n-3 PUFA supplementation was associated with a modest but measurable increase in muscle strength. It also showed potential benefits for lower-limb physical performance and muscle mass. The authors conclude that marine-derived n-3 PUFAs in particular "may offer preliminary benefits" in slowing age-related declines among healthy older adults.
The wording is cautious: "modest," "potential," "preliminary." Nothing here suggests fish oil rebuilds muscle on its own.
Where the Evidence Is Strongest (and Weakest)
The pattern is lopsided. The review found moderate certainty for some outcomes:
- Lower-body strength
- Lower-extremity physical function
Other outcomes were rated low or very low certainty:
- Grip strength
- Walking speed
- Upper-body strength
The authors attribute the weaker ratings largely to the small number of trials and methodological limitations. In practice, the signal is clearest for the legs, the muscles that matter for standing from a chair, climbing stairs, and staying steady. For grip, gait speed, and upper-body strength, the honest answer is that we cannot say yet.
The Catch: A Lot of Overlap
The 14 studies are not 14 independent votes. The review found a CCA of 14.02%, which indicates substantial redundancy: the meta-analyses drew on many of the same underlying trials. That can make the evidence look more consistent than it really is. Combined with the low-to-very-low certainty ratings for most outcomes, the authors say the overall reliability of the findings "may be compromised." They call for large, rigorous RCTs before any evidence-based guidelines can be written for sarcopenia.
What This Means for You
Who it may be for: Adults aged 55 and older, especially those worried about sarcopenia, the age-related loss of muscle mass and function. The evidence comes from healthy older adults, so it does not prove benefit in people with diagnosed disease.
Which type to consider: Marine omega-3s (EPA/DHA) were the most commonly studied form, and the authors highlight them as the most promising. Flaxseed-based ALA appeared in only a few studies, so the case for it is thinner.
Dose: The review covered 1.3 to 14 g/day and does not name a best dose. Higher is not shown to be better, and 14 g/day is far beyond what most people take. Check the EPA+DHA content on the label, not just the total oil, and talk with a clinician about the amount that suits you.
Duration: Trials lasted 6 weeks to 6 months. Think in terms of months of consistent use, not days. Timing of the daily dose was not a finding of this review. Taking fish oil with a meal is common practice, but that is general advice, not something the paper tested.
Pair it with training: This review does not show that fish oil works alone. The sensible way to use a supplement for a muscle problem is on top of the proven basics: resistance training a couple of times a week and adequate protein. Treat fish oil as a possible add-on, not a replacement.
Realistic expectations: Expect modest effects, with the best odds for leg strength. Do not expect dramatic changes in grip strength or walking speed based on this evidence.
Who should skip it or ask first: This falls outside the paper, but anyone on blood thinners, with a fish or shellfish allergy, facing surgery, or managing a chronic condition should check with a doctor or pharmacist before starting high-dose omega-3s. Those at the top of the studied dose range deserve extra caution.
The Bottom Line
Fish oil is not a miracle muscle builder, but this umbrella review suggests it may give older adults a small edge, mostly in lower-body strength and function. The evidence is early, overlapping, and often low in certainty, so the safest reading is "promising, not proven." Until bigger trials arrive, resistance training and good nutrition remain the foundation, and marine omega-3s are a reasonable, evidence-informed extra for the 55-plus crowd.
